Rusfertide effectively maintained hematocrit control below 45% and reduced phlebotomy eligibility in PV patients through 52 weeks. Patients switching from placebo to rusfertide achieved rapid and ...

Takeda and Protagonist Therapeutics have submitted a new drug application to the FDA for rusfertide for adults with ...

OSAKA, Japan & CAMBRIDGE, Mass. & NEWARK, Calif., January 05, 2026--Takeda (TSE:4502/NYSE:TAK) and Protagonist Therapeutics (Nasdaq: PTGX) ("Protagonist") announced the submission of a New Drug ...

Takeda & Protagonist submit NDA to US FDA seeking approval for rusfertide to treat polycythemia vera: Osaka, Japan Wednesday, January 7, 2026, 17:00 Hrs [IST] Takeda, focused on c ...

The entrepreneurial Moro has already bought two helicopters and hopes to start flying rescues in Pakistan later this year.

Ozone that protects us from the sun's harmful UV rays, when in an indoor space, reacts with oils present on skin, wall paint, ...

The UAE Ministry of Education has introduced an automatic degree recognition system for 34 universities, streamlining the ...

Consumer Report Details Low Testosterone Treatment Costs, LabCorp and Quest Lab Testing, Licensed Provider Access, and What ...

Takeda (TAK) and Protagonist Therapeutics (PTGX) announced the submission of a new drug application to the FDA seeking approval of rusfertide for ...

Staying on top of your health isn’t just about hitting the gym, eating well, or getting the necessary vaccines. It also means ...

For centuries, so-called vital mushrooms like Cordyceps or Reishi have been used in traditional medicine in Asia. Modern ...

Learn more about whether Helios Technologies, Inc. or Standex International Corporation is a better investment based on ...